Third Harmonic Bio’s $213.1 Million IPO

Martina Bellini
Tagged:

Fenwick represented Third Harmonic Bio, Inc. on the deal.Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now